Zoeken | Pikumil

Harshasharma Harshasharma toegevoegd een audio Other
2026-05-29 08:52:47 -

GLP-1 Receptor Agonists Obesity Drugs Market: Size, Share, and Future Growth
According to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period With the clear...

0 Reacties 0 aandelen 402 Views 0 voorbeeld

Please log in to like, share and comment!
Rutuja Deshmukh toegevoegd een audio Other
2026-06-22 11:02:42 -

GLP-1 Receptor Agonist Market Trends in Advanced Biopharmaceutical Development
The global GLP-1 Receptor Agonist Market was valued at USD 66.4 billion in 2025 and is projected to grow from USD 82.0 billion in 2026 to USD 185.3 billion by 2033, registering a CAGR of 12.4% from 2026 to 2033. The market is witnessing remarkable growth due to the rising prevalence of type 2 diabetes, obesity, and other metabolic disorders, coupled with increasing clinical acceptance...

0 Reacties 0 aandelen 2K Views 0 voorbeeld

Please log in to like, share and comment!
Rutuja Deshmukh toegevoegd een audio Other
2026-07-24 10:52:46 -

GLP-1 Agonists Weight Loss Drugs Market Supply Chain Analysis
The global GLP-1 Agonists Weight Loss Drugs Market was valued at USD 13.8 billion in 2024 and is projected to grow from USD 27.5 billion in 2026 to USD 48.8 billion by 2030, registering a CAGR of 18.5% from 2025 to 2030. North America dominated the market with a 75.5% revenue share in 2024, supported by high obesity prevalence, favorable reimbursement policies, strong pharmaceutical...

0 Reacties 0 aandelen 615 Views 0 voorbeeld

Please log in to like, share and comment!
Aishwarya Chavan toegevoegd een audio Religion
2025-11-20 14:51:30 -

Therapeutic Radiopharmaceuticals MarketPotential: Size, Share, Trends, and Future Outlook
"Future of Executive Summary GLP-1 Analogues Market: Size and Share Dynamics The global GLP-1 analogues market size was valued at USD 32.19 billion in 2024 and is expected to reach USD 346.06 billion by 2032, at a CAGR of 34.56% during the forecast period To thrive in this rapidly transforming marketplace, today’s businesses call for innovative and...

0 Reacties 0 aandelen 794 Views 0 voorbeeld

Please log in to like, share and comment!
Rina Choudhary toegevoegd een audio Other
2026-06-17 15:33:53 -

Diabetes Treatments Market Size, Share, and Growth Forecast to 2030
According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...

0 Reacties 0 aandelen 6K Views 0 voorbeeld

Please log in to like, share and comment!
Priti Jain toegevoegd een audio Other
2026-10-09 05:29:02 -

GLP-1 Market: Research Advancements and Industry Developments
The GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...

0 Reacties 0 aandelen 81 Views 0 voorbeeld

Please log in to like, share and comment!